Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

U.S. grants first approval for GelTex's novel phosphate-binding polymer therapeutic

Nov. 3, 1998

Synthelabo team presents new agents for incontinence

Nov. 3, 1998

Basis of beneficial effects of cactus flower in BPH

Oct. 30, 1998

Milkhaus successfully completes phase II trial of BPH therapeutic

Oct. 21, 1998

Celsion ready to begin BPH treatment studies

Oct. 20, 1998

Boston Scientific to copromote Targis System for BPH

Oct. 16, 1998

Creative BioMolecules modifies Biogen partnership

Oct. 16, 1998

Asahi expects approval of dysuria Rx in near future

Oct. 14, 1998

Abbott will collaborate with Nippon Shinyaku on development of incontinence Rx

Oct. 14, 1998

Fujisawa withdraws NDA for vamicamide

Oct. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...